Navigation Links
Sundia Receives the Highest Growth Potential Award from Zhangjiang
Date:8/31/2009

SHANGHAI, Aug. 31 /PRNewswire-Asia/ -- Sundia MediTech Company, a leading pharmaceutical R&D outsourcing Service Company in China, announced today that it received the Highest Growth Potential Award from Zhangjiang Hi-Tech Park on August 26. The award was announced at the 10th anniversary celebration of "Focus on Zhangjiang Festival" in August. Dr. Tong Xu, Sundia's Vice President for Process Chemistry and GMP Operations, attended the ceremony. "Zhangjiang Hi-Tech Park is China's most successful high technology park which many top high tech start-up companies in China have chosen as their home. I am honored to be here today to receive this award for Sundia," said Dr. Xu.

In August of 1999, Shanghai Municipal Government declared a "Focus on Zhangjiang" strategy to utilize all resources of the city with support from the central Chinese government to make Zhangjiang Park the technology innovation highland of the country. Ten years later, Zhangjiang has become the national biotech & pharmaceutical industry base, which has attracted more than 300 biotech and pharmaceutical companies from all over the world. Sundia Meditech Company, founded in 2004 in Zhangjiang, has kept a high speed for business growth in the past 5 years. For the year 2008, Sundia ranked #52 in Deloitte technology Fast 500 Asia Pacific list, and #16 in Fast 50 China list, with its 928% revenue growth. It was named one of the 50 best companies for investment in 2007 and 2008.

"We are lucky that we made the decision to come to Zhangjiang to start Sundia 5 years ago," said Dr. Wang Xiaochuan, Sundia's Chairman and CEO. "Zhangjiang Hi-Tech Park announced a New Drug Incubation Platform earlier this year to combine venture capitals, intellectual properties, and CRO resources together to support new drug discovery and development programs in the park. Sundia was selected by Zhangjiang as the leading CRO provider to this platform based on our outstanding track record in CRO services. We will try our best to support Zhangjiang Hi-Tech Park to make this platform a success."

About Sundia MediTech

Sundia MediTech Company is a leading integrated pharmaceutical contract research organization (CRO) company based in Shanghai, China. It was founded in Shanghai in 2004 by a group of veterans of the US pharmaceutical industry to provide R&D outsourcing services to biotech and pharmaceutical companies worldwide, ranging from chemical services, medicinal chemistry, biological service, new technology platforms and services, and pharmaceutical development.


'/>"/>
SOURCE Sundia MediTech Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. CRO Company Sundia Welcomes New Members to Its Executive Team
2. Finland Biotech Delegation Visits Sundia
3. Sundia MediTech Appoints Dr. Chen Chen as Senior VP of Chemistry
4. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
5. DaVita Receives Civil Complaint
6. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
7. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
8. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
9. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
10. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
11. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... February 21, 2017 , ... Individuals who have been diagnosed ... surgery, treatment, therapy and management. Regular exercise in proper environments has been shown ... their diseases. On February 23, 2017, 1:00-2:00 p.m. E.S.T., a dynamic HydroWorx ...
(Date:2/21/2017)... NJ (PRWEB) , ... February 21, 2017 , ... ... research and conference coverage in veterinary medicine, will be launching its first bi-monthly ... animal health and medicine, business and practice management, and One Health. , ...
(Date:2/21/2017)... ... 2017 , ... Atlanta-based Jvion, the leading cognitive clinical science ... practice. Predixion, which raised $42M+ to date, received $20M in its third ... Ventures, and Software AG , will bring top industry talent and an impressive ...
(Date:2/21/2017)... ... February 21, 2017 , ... A February 6 article on Healio ... It found that the treatments have led to significant improvements in weight loss and ... efforts. It also noted very few problematic results relating to the treatment. Beverly Hills ...
(Date:2/20/2017)... Ill. (PRWEB) , ... February 20, 2017 , ... ... to reduce the rate at which women are called back for additional examinations ... journal Radiology . , In 2011, the U.S. Food and Drug Administration ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... BANGALORE , February 21, 2017 ... Appropriate Technology for Adoption by Plastic Industry  ... STEER, ... and functionalise materials in the fields of plastics, pharmaceuticals, ... collaboration with Merck KGaA, Darmstadt, Germany ...
(Date:2/21/2017)... 21, 2017 ... new imaging solution that connects Lexmark multifunction printers (MFPs) ... the world,s leading scanning and indexing software solutions for ... hospitals to use a Lexmark MFP at the point ... workflow, helping facilities reach HIMSS Stage 7 ...
(Date:2/21/2017)... Feb. 21, 2017  International Isotopes Inc. (OTCQB: INIS) ... placement with certain investors for approximately $3.4 million of ... Series C Convertible Redeemable Preferred Stock (the "Series C ... annual rate of 6% and is convertible into common ... use the proceeds for operating capital, to pay off ...
Breaking Medicine Technology: